Commit To Buy Cara Therapeutics At $7.50, Earn 34.5% Annualized Using Options
January 14, 2016 at 14:18 PM EST
Investors considering a purchase of Cara Therapeutics Inc (CARA) shares, but cautious about paying the going market price of $10.79/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May put at the $7.50 strike, which has a bid at the time of this writing of 90 cents..